ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Commerce Bank

Commerce Bank reduced its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 3.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,861 shares of the medical instruments supplier’s stock after selling 115 shares during the period. Commerce Bank’s holdings in ICU Medical were worth $668,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Advisory Services Network LLC acquired a new position in ICU Medical during the second quarter worth about $43,000. Van ECK Associates Corp grew its holdings in ICU Medical by 115.3% during the second quarter. Van ECK Associates Corp now owns 239 shares of the medical instruments supplier’s stock worth $49,000 after acquiring an additional 128 shares during the period. Signaturefd LLC grew its holdings in ICU Medical by 103.3% during the third quarter. Signaturefd LLC now owns 370 shares of the medical instruments supplier’s stock worth $86,000 after acquiring an additional 188 shares during the period. Meeder Asset Management Inc. grew its holdings in ICU Medical by 40.8% during the third quarter. Meeder Asset Management Inc. now owns 404 shares of the medical instruments supplier’s stock worth $95,000 after acquiring an additional 117 shares during the period. Finally, Advisor Group Holdings Inc. increased its stake in ICU Medical by 9.1% in the 2nd quarter. Advisor Group Holdings Inc. now owns 872 shares of the medical instruments supplier’s stock worth $181,000 after purchasing an additional 73 shares in the last quarter. 93.27% of the stock is currently owned by hedge funds and other institutional investors.

Separately, KeyCorp dropped their price target on ICU Medical from $302.00 to $280.00 and set an “overweight” rating on the stock in a research note on Friday, October 22nd.

Shares of ICUI opened at $219.99 on Friday. ICU Medical, Inc. has a 1-year low of $183.39 and a 1-year high of $282.00. The stock has a market capitalization of $4.67 billion, a P/E ratio of 43.65 and a beta of 0.51. The business’s 50-day moving average price is $233.76 and its 200 day moving average price is $220.98.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, November 3rd. The medical instruments supplier reported $2.07 EPS for the quarter, topping the Zacks’ consensus estimate of $1.57 by $0.50. ICU Medical had a return on equity of 8.72% and a net margin of 8.44%. The firm had revenue of $336.06 million during the quarter, compared to analyst estimates of $314.20 million. During the same period last year, the company posted $1.61 EPS. Equities analysts anticipate that ICU Medical, Inc. will post 6.28 EPS for the current year.

In other ICU Medical news, CEO Vivek Jain sold 164 shares of the firm’s stock in a transaction dated Tuesday, December 28th. The stock was sold at an average price of $240.00, for a total transaction of $39,360.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 9.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.

Further Reading: What are different types of coverage ratios?

Want to see what other hedge funds are holding ICUI? Visit to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with's FREE daily email newsletter.